Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
97,693,461
-
Total 13F shares
-
3,290,303
-
Share change
-
-264,803
-
Total reported value
-
$10,923,496
-
Price per share
-
$3.32
-
Number of holders
-
33
-
Value change
-
-$819,783
-
Number of buys
-
4
-
Number of sells
-
8
Institutional Holders of Rani Therapeutics Holdings, Inc. - Common Stock (RANI) as of Q4 2023
As of 31 Dec 2023,
Rani Therapeutics Holdings, Inc. - Common Stock (RANI) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,290,303 shares.
The largest 10 holders included
VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, UNITED SERVICES AUTOMOBILE ASSOCIATION, Alphabet Inc., TAKEDA PHARMACEUTICAL CO LTD, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., LASRY MARC, and Alpha Square Group S, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.